Phacilitate Leaders World

Conference speakers

Conference speakers

  • Letter
    • R
  • Laszlo  Radvanyi

    Dr Laszlo Radvanyi

    Senior Vice President Head of ImmunoOncology Translational Innovation Platform, EMD Serono
  • Shahin Rafii

    Dr Shahin Rafii

    Professor of Medicine, Weill Cornell
  • Qasim Rafiq

    Qasim Rafiq

    Associate Professor, Bioprocessing of Regenerative, Cellular & Gene Therapies, UCL
  • Anthony Ramirez

    Anthony Ramirez

    Executive Director, Manufacturing, 4D Molecular Therapeutics
  • Thomas Rando

    Dr Thomas Rando

    Professor Neurology & Director, Glenn Laboratories for the Bi9ology of Aging / Director, Center for Tissue Regeneration, Repair, and Restoration, Stanford University School of Medicine / Palo Alto, VA Medical Center
  • Alise  Reicin

    Dr Alise Reicin

    SVP, Head of Global Clinical Development, EMD Serono
  • Jim Richardson

    Dr Jim Richardson

    Deputy Chief, Preclinical Translational Programs, Foundation Fighting Blindness
  • Camillo Ricordi

    Dr Camillo Ricordi

    Professor and Director, Diabetes Research Institute and Cell Transplant Center, University of Miami Miller School of Medicine
  • Anthony Ridgway

    Dr Anthony Ridgway

    Acting Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics, Health Canada
  • Rodney  Rietze, PhD

    Rodney Rietze, PhD

    Bioprocess Innovation & Enabling Technologies, Immuno-Oncology, Novartis Institutes for Biomedical Research
  • Donna Rill

    Donna Rill

    Vice President of Manufacturing, Cell Medica
  • Isabelle Riviere

    Dr Isabelle Riviere

    Director, Michael G. Harris Cell Therapy & Cell Engineering Facility, Memorial Sloan Kettering Cancer Center
  • Ragan Robertson

    Ragan Robertson

    Business Development and Information Systems Officer, UCLA Technology Development Group
  • David Rodriguez

    David Rodriguez

    Director Of Business Development, FreeMind Group
  • Ricardo Rodriguez

    Dr Ricardo Rodriguez

    Past President, IFATS
  • Marsha Rolle

    Dr Marsha Rolle

    Associate Professor, Biomedical Engineering, Worcester Polytechnic Institute
  • Martha Rook

    Martha Rook

    SVP, Head of Manufacturing, Sigilon Therapeutics
  • Eric Roos

    Eric Roos

    Strategic Alliances Leader, Cell Therapy, Thermo Fisher Scientific
  • Lloyd Rose

    Dr Lloyd Rose

    Regenerative Medicine Program Area Manager, Clinical and Rehabilitative Medicine Research Program, US Army Medical Research & Materiel Command
  • Shelley Ross

    Shelley Ross

    President, Cure Alliance
  • Jon Rowley

    Dr Jon Rowley

    Founder & Chief Product Officer, RoosterBio Inc
  • Beth Roxland

    Beth Roxland

    Senior Consultant on Law, Health, Policy and Ethics, Roxland Consultants Ltd
  • Qinhua Cindy Ru

    Dr Qinhua Cindy Ru

    Managing Director, CRC Oncology Corp.
  • Peter Rubin

    Dr Peter Rubin

    Endowed Professor & Chair of Plastic Surgery, Director UPMC Wound Healing Services, Professor of Bioengineering, University of Pittsburgh Medical Center
  • Alex Rubinsteyn

    Dr Alex Rubinsteyn

    Researcher, Icahn School of Medicine at Mount Sinai
  • Sean Russell

    Sean Russell

    Director, Regulatory Affairs, Achilles Therapeutics Limited
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman